首页> 外文期刊>International journal of hyperthermia: The official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group >Ultrasound-guided high-intensity focused ultrasound (USgHIFU) ablation for the treatment of patients with adenomyosis and prior abdominal surgical scars: A retrospective study
【24h】

Ultrasound-guided high-intensity focused ultrasound (USgHIFU) ablation for the treatment of patients with adenomyosis and prior abdominal surgical scars: A retrospective study

机译:超声引导的高强度聚焦超声(USGHIFU)消融治疗腺小衰竭患者和腹部手术疤痕:回顾性研究

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: The aim of this paper was to retrospectively compare the therapeutic efficacy and adverse effects of ultrasound-guided high-intensity focused ultrasound (USgHIFU) treatment for adenomyotic patients with or without prior abdominal surgical scars. Methods: From January 2011 to March 2014, 534 patients with adenomyosis were referred for HIFU treatment. Among them, 118 patients had prior abdominal surgical scars, 416 patients did not have prior abdominal surgical scars. Contrast-enhanced MRI was used to evaluate the treatment outcomes. All the adverse effects were recorded. Results: All patients completed USgHIFU treatment. A fractional ablation of 74.8 +/- 27.8% was achieved in the group of patients without abdominal scars; the fractional ablation was 75.6 +/- 22.3% in the group of patients with prior abdominal surgical scars. No significant difference in fractional ablation between the two groups was observed (p>0.05). The rate of skin burn in the group of patients with prior abdominal surgical scars was significantly higher than that in the group without abdominal scars (2.5% vs. 0.2%, p<0.05), but it is still acceptable. Conclusion: The prior abdominal surgical scars have no significant influence on the effectiveness of HIFU treatment for adenomyosis. The risk of skin burn is higher in patients with abdominal scars than without, but the incidence rate is still acceptable.
机译:目的:本文的目的是回顾性地比较超声波引导的高强度聚焦超声(USGHIFU)治疗腺瘤患者的治疗效果和不利影响,患有或没有现有的腹部手术疤痕。方法:2011年1月至2014年3月,534例腺小症患者称为HIFU治疗。其中,118名患者患有现有腹部手术疤痕,416名患者没有现有的腹部手术疤痕。对比增强的MRI用于评估治疗结果。记录了所有不利影响。结果:所有患者均完成USGHIFU治疗。在没有腹部疤痕的患者组中,在74.8 +/- 27.8%的分数消融;本组患有现有腹部手术疤痕的患者组分数烧蚀为75.6 +/-22.3%。观察到两组之间的分数消融没有显着差异(p> 0.05)。现有腹部手术疤痕组中的皮肤燃烧率明显高于腹部疤痕(2.5%vs.0.2%,P <0.05),但仍然可以接受。结论:现有腹部外科瘢痕对HIFU治疗对腺型病的有效性没有显着影响。腹部伤疤的患者皮肤燃烧的风险高于没有,但发病率仍然是可接受的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号